UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 17, 2021
Accession Number:
Submission Type:
CIK:
0001157075
Company Name:
PharmaCyte Biotech, Inc.
File Number:
333-260849